Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine solutions for prevention of haemodialysis central venous catheter infections
2010-019984-12Phase 4Completed
- Sponsor
- Tallaght University Hospital
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of chlorhexidine and Isopropyl alcohol in central venous catheter-related bloodstream infection (CRBSI) (3 arms), sponsored by Tallaght University Hospital. Primary endpoints: Bloodstream infection secondary to central venous catheter, Catheter-associated bloodstream infection and 4 more. Started May 2010; status: completed.
02
Drugs
chlorhexidineIsopropyl alcohol
03
Conditions
central venous catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on 2010-019984-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019984-12.